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Abstract
Introduction: Folate and one-carbon metabolism are linked to cancer risk through their integral role in DNA synthesis and
methylation. Variation in one-carbon metabolism genes, particularly MTHFR, has been associated with risk of a number of
cancers in epidemiologic studies, but little is known regarding renal cancer.
Methods: Tag single nucleotide polymorphisms (SNPs) selected to produce high genomic coverage of 13 gene regions of
one-carbon metabolism (ALDH1L1, BHMT, CBS, FOLR1, MTHFR, MTR, MTRR, SHMT1, SLC19A1, TYMS) and the closely associated
glutathione synthesis pathway (CTH, GGH, GSS) were genotyped for 777 renal cell carcinoma (RCC) cases and 1,035 controls
in the Central and Eastern European Renal Cancer case-control study. Associations of individual SNPs (n=163) with RCC risk
were calculated using unconditional logistic regression adjusted for age, sex and study center. Minimum p-value
permutation (Min-P) tests were used to identify gene regions associated with risk, and haplotypes were evaluated within
these genes.
Results: The strongest associations with RCC risk were observed for SLC19A1 (Pmin-P=0.03) and MTHFR (Pmin-P=0.13). A
haplotype consisting of four SNPs in SLC19A1 (rs12483553, rs2838950, rs2838951, and rs17004785) was associated with a
37% increased risk (p=0.02), and exploratory stratified analysis suggested the association was only significant among those
in the lowest tertile of vegetable intake.
Conclusions: To our knowledge, this is the first study to comprehensively examine variation in one-carbon metabolism
genes in relation to RCC risk. We identified a novel association with SLC19A1, which is important for transport of folate into
cells. Replication in other populations is required to confirm these findings.
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Introduction
One-carbon metabolism refers to a system of interdependent
metabolic pathways that facilitate the transfer of one-carbon units
and ultimately provide the precursors needed for DNA synthesis
and repair as well as DNA methylation. Interconversion of various
forms of folate is at the foundation of one-carbon metabolism, and
folate deficiency has been shown to cause DNA strand breaks,
diminished DNA repair capacity, and aberrant methylation
patterns [1]. Folate intake has been associated with risk of a
number of cancers, including those of the colorectum, esophagus,
stomach, and pancreas [2–4]. Little is known about the
associations between one-carbon metabolism and renal cancer,
though one study suggested folate deficiency is associated with
increased risk [5].
A candidate gene analysis by Moore et al. in a large renal cell
carcinoma (RCC) case-control study conducted in Central and
Eastern Europe examined 10 SNPs in 5 one-carbon metabolism
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26165genes and found an association between the MTHFR 677C.T
polymorphism and RCC risk [6]. This polymorphism, which
results in reduced enzyme activity, has previously been associated
with various cancers, with the most consistent evidence pointing to
a reduced risk of colorectal cancer [7–10]. Other genes involved in
one-carbon metabolism reactions include TYMS, MTR, MTRR,
BHMT, SHMT, and ALDH1L1 (Table 1, Figure S1). The FOLR1,
SLC19A1 and GGH genes may also be important since they are
involved in folate transport and availability. CBS, CTH and GSS
are part of a related pathway in which homocysteine is converted
to glutathione, which has been shown to modify cancer risk due to
its role in antioxidant reactions and Phase II xenobiotic
metabolism [11]. The association of these genes with renal cancer
risk is unknown.
We have expanded on the previous findings of Moore et al. to
more comprehensively investigate genetic variation across
MTHFR and 12 additional candidate genes involved in folate
transport, one-carbon metabolism and glutathione synthesis. We
examined the relationship between RCC risk and 163 tag SNPs
that provided high genomic coverage of 13 target gene regions
among RCC cases and controls from Central Europe, an area
with some of the highest rates of RCC incidence and mortality
worldwide [12].
Materials and Methods
Study Population
The Central and Eastern European Renal Cell Cancer
(CEERCC) Study, details of which have been described previously
[13], is a multi-center, hospital-based case-control study conducted
from August 1999 to January 2003. Cases consisted of 1,097
patients newly diagnosed with histologically-confirmed RCC, ages
20–79, recruited from centers in Russia (Moscow), Romania
(Bucharest), Poland (Lodz) and Czech Republic (Prague, Olo-
mouc, Ceske Budejovice, Brno). Diagnostic information was
extracted from hospital records by trained medical staff. Eligible
controls included 1,497 patients admitted to the same hospital as
cases, but for conditions not related to smoking or genitourinary
disorders. Controls were frequency matched to cases based on age
(63 years), sex and study center (including hospital of recruit-
ment), and both cases and controls were required to have been
residents of the study center area for at least one year at the time of
recruitment. Response rates ranged from 90.0–98.6% for cases
and from 90.3–96.1% for controls, and all study participants were
Caucasian. Blood samples were collected and genomic DNA,
extracted from whole blood buffy coat using a standard phenol-
chloroform extraction method, was obtained for 987 cases (90%)
and 1,298 controls (88%). Written informed consent was obtained
from all patients and their physicians, and the study was approved
by the institutional review boards of the National Cancer Institute
(NCI), the International Agency for Research on Cancer (IARC),
and each study center.
Data Collection
Trained personnel conducted in-person interviews and used
standardized questionnaires to collect information on demograph-
ics, education, tobacco smoking, diet, anthropometric measures,
and medical, family and occupation histories. All cases were
interviewed within three months of RCC diagnosis. Assessment of
dietary intake has been described previously [14]. Briefly, the food
frequency questionnaire (FFQ) consisted of 23 food items/
categories, selected with local investigators to capture consumption
patterns in these specific regions. Frequency of consumption of
each food item was assessed using six categories, ranging from
never to daily. Food group categories were formed on the basis of
intake of similar foods (e.g. cruciferous vegetables included brussel
sprouts, broccoli and cabbage). The assessment of vegetable
intake, designed to comprehensively cover intake in this region
through 1999 [14], was based on the eight specific vegetables
commonly eaten in the region (carrots, cabbage, spinach, broccoli,
brussel sprouts, onion, pumpkin, tomatoes) plus an additional
category for ‘‘other fresh and preserved vegetables’’. Tertiles of
vegetable intake were calculated based on the consumption
frequencies reported among controls.
Genotyping
Genotyping was performed at the NCI’s Core Genotyping
Facility (CGF) using an Illumina GoldenGateH Oligo Pool All
(OPA) assay. CGF staff was blinded to case-control status and
samples were blinded and randomized on PCR plates. Duplicate
genotyping was performed for a randomly selected 5% of the
samples for quality control. Genotyping was performed on a subset
of 777 cases (70.8%) and 1,035 controls (70.1%) who provided
sufficient quality and quantity of DNA required for use of the
IlluminaH OPA assay. The genotyping completion rate was
greater than 98% for all SNPs except rs6519519 (97%). The
quality control concordance rate was 98% or greater for all SNPs
except rs1476413 (94%), rs11121832 (96%), rs234712 (95%),
rs4646768 (97%), and rs13069815 (96%). Nine candidate SNPs
(Table S1) were genotyped previously at CGF using a validated
TaqMan assay, details of which can be found at http://
snp500cancer.nci.nih.gov/home.cfm. Methods and results for
these nine SNPs, previously reported by Moore et al. [5], were
included in our analyses for gene-based tests as well as the
identification and testing of haplotypes in multivariable and
stratified analyses.
Genes were selected a priori based on their role in one-carbon
metabolism or the closely associated glutathione synthesis pathway
(CBS, CTH and GSS). Genotypes were obtained for 167 tag SNPs
selected to provide high genomic coverage (80–90%) for 13
candidate genes involved in one-carbon metabolism and glutathi-
one synthesis (see Table 1, Figure S1). Tag SNPs were selected
from among common variants (minor allele frequencies $5%)
found in Caucasians using a tag SNP method [15] with an
r
2.0.80. The regions 20 kb upstream of the transcription start site
and 10 kb downstream of the last exon using HapMap CEU data
(http://www.hapmap.org) were included for tag SNP selection to
ensure thorough coverage of each target gene. Nonsynonymous
SNPs and those with putative functional significance were also
included in our analysis. All SNPs included in this study are
reported in the National Cancer Institute’s SNP500Cancer
database (http://snp500cancer.nci.nih.gov) [16]. No deviations
from expected Hardy-Weinberg proportions (chi-square tests,
p,0.05 for deviation) were observed for genotype frequencies
among the controls.
Statistical Analyses
A sequence of analyses was used to comprehensively examine
the associations of single SNPs, genes, gene regions, and
haplotypes with RCC risk while accounting for multiple testing.
Odds ratios (ORs) and 95% confidence intervals (CIs) for the
association of each individual SNP with RCC risk were
determined using unconditional logistic regression assuming a
codominant model of inheritance for SNP genotypes. For linear
trend tests the homozygous common, heterozygous and homozy-
gous rare groups were coded as 0, 1 or 2 respectively,
corresponding to the number of rare alleles. Logistic regression
models were adjusted for age (continuous), sex, and country.
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PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e26165Table 1. Individual SNP and gene-based global minimum p-values for candidate one-carbon metabolism genes and risk of renal
cell carcinoma.
Gene Name (alias) Gene Function
Chromosome
Location
Number of
Tag SNPs
Minimum
P-trend
1,2
FDR-
adjusted
P-trend
1,3
Adjusted
Min-P Test
[1] SLC19A1: Solute Carrier Family
19 (folate transporter), member 1
(CHMD, FOLT, IFC1, REFC, RFC1)
Carrier-mediated transport of folate
compounds into cells; plays a role in
maintaining intracellular concentrations
of folate.
21q22.3 6 0.01 0.03 0.032
[2] MTHFR: 5,10-
Methylenetetrahydrofolate Reductase
(NADPH)
Irreversible conversion of 5,10-
methylenetetrahydrofolate to 5-
methylenetetrahydrofolate, which then
participates in conversion of
homocysteine to methionine and
subsequently S-adenosylmethionine; key
regulatory enzyme in folate metabolism.
1p36.3 8 0.02 0.16 0.130
[3] BHMT: Betaine-Homocysteine
Methyltransferase
Involved in the regulation of
homocysteine metabolism. Converts
betaine and homocysteine to
dimethylglycine and methionine,
respectively.
5q13.1–q15 13 0.03 0.35 0.337
[4] MTR: 5-Methyltetrahydrofolate-
Homocysteine Methyltransferase
(MS, FLJ33168, FLJ43216, FLJ45386)
Catalyzes the final step in methionine
biosynthesis in a reaction that
involves cobalamin (B12) and
5-methyltetrahydrofolate.
1q43 9 0.05 0.21 0.371
[NS] GGH: Gamma-Glutamyl
Hydrolase (conjugase,
folylpolygammaglutamyl hydrolase,
GH)
Hydrolyzes the polyglutamate
sidechains of pteroylpolyglutamates,
the predominant form of the folate in
food; may play an important role in
the bioavailability of dietary
pteroylpolyglutamates and in the
metabolism of pteroylpolyglutamates
and antifolates
8q12.3 6 0.09 0.33 0.467
Gene Name (alias) Gene Function
Chromosome
Location
Number of
Tag SNPs
Minimum
P-trend
1,2
FDR-
adjusted
P-trend
1,3
Adjusted
Min-P Test
[5] TYMS: Thymidylate Synthetase
(TS, TMS, TSase, HsT422, MGC88736)
Catalyzes the methylation of
deoxyuridylate to deoxythymidylate
using 5,10-methylenetetrahydrofolate
as a cofactor; maintains the dTMP pool
critical for DNA replication and repair.
18p11.32 14 0.09 0.46 0.601
[6] CTH: Cystathionase (Cystathionine
gamma-lyase, gamma cystathionase,
MGC 9471)
Converts cystathione derived from
methionine into cysteine. Glutathione
synthesis in the liver is dependent upon
the availability of cysteine.
1p31.1 13 0.08 0.72 0.667
[7] ALDH1L1: Aldehyde
Dehydrogenase 1 Family, member L1
(FTHFD, DKFZp781N0997)
Catalyzes the conversion of 10-
formyltetrahydrofolate, NADP, and
water to tetrahydrofolate, NADPH,
and carbon dioxide.
3q21.2 34 0.04 0.84 0.778
[8] FOLR1: Folate Receptor 1 (FBP,
FOLR, MOv18, FR-alpha)
Binds to folate and reduced folic acid
derivatives and mediates delivery of 5-
methyltetrahydrofolate to the interior
of cells.
11q13.3–q14.1 3 0.43 0.75 0.786
[9] CBS: Cystathionine-Beta-Synthase
(HIP-4)
Catalyzes the conversion of
homocysteine to cystathionine, the
first step in the transsulfuration pathway.
21q22.3 25 0.09 0.97 0.922
[10] SHMT1: Serine
Hydroxymethyltransferase 1 (SHMT,
CSHMT, MGC 15229, MGC 24556)
Catalyzes the reversible conversion of
serine and tetrahydrofolate to glycine
and 5,10-methylene tetrahydrofolate.
This reaction provides one carbon
units for synthesis of methionine,
thymidylate, and purines.
17p11.2 5 0.51 0.89 0.970
One-Carbon Metabolism Genes and Renal Cancer Risk
PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e26165Further adjustment for smoking, self-reported hypertension or
body mass index did not appreciably change the risk estimates
(,5%). Multiplicative interactions between SNPs and these RCC
risk factors were evaluated by likelihood ratio tests comparing
models with and without interaction terms, but we found no
evidence of effect modification.
Global significance of associations between individual genes and
RCC risk was assessed using the minimum p-value permutation
(min-P) test [17,18], which combines information on the set of
SNP-RCC associations within a gene and accounts for the
correlation between SNPs. Inferences are based on the permuta-
tion distribution of the minimum p-value among the set of SNPs in
a gene. Min-P tests were adjusted for multiple comparisons among
genes using Benjamini and Hochberg’s False Discovery Rate
(FDR) procedure [19,20]. For genes identified by the single SNP
or min-P tests, a haplowalk sliding-window approach was
employed in which consecutive 3 SNP windows were examined
to identify chromosome regions of interest for further analysis of
haplotypes. For each 3 SNP window, the Haplostats package
(version 1.3.1) in R (version 2.4.1) was used to reconstruct
haplotype frequencies in cases and controls using an expectation
maximization (EM) algorithm and to test for association with case-
control status using generalized linear models (haplo.glm) and a
Wald test. SNP windows with an FDR-adjusted p-value below 0.1
were considered to denote a region of interest.
Linkage disequilibrium (LD) between SNPs among control
subjects was determined using the Haploview program [21] to
calculate r
2 values. Based on the results of the haplowalk
procedure and the observed LD structure, haplotype-blocks were
selected for further analysis. For these blocks, haplotypes were
reconstructed and associations with case-control status (ORs and
95% CIs) were evaluated in Haplostats in R, with adjustment for
age (,50, 50–,60, 60–,70 and 70+ years), sex and study center.
The most common haplotype served as the reference, and
haplotypes with an estimated frequency of less than 5% were
combined into a separate ‘‘rare’’ haplotype group. Further
analyses examined the haplotype associations within strata of
vegetable or alcohol intake (based on tertiles of consumption
among controls). A likelihood ratio test comparing the fit of models
with and without interaction terms was used to evaluate
heterogeneity of genotype frequencies among countries, but we
did not observe any evidence of heterogeneity. Statistical analyses
were conducted using SAS version 9.1 (SAS Institute, Cary, NC),
except where otherwise noted.
Results
Demographic and lifestyle characteristics of all participants and
genotyped participants in the CEERCC study are shown in
Table 2. The distribution of RCC risk factors in successfully
genotyped participants was similar to that of all participants. The
majority of participants were from the Czech Republic, and cases
were more likely to be from that country than controls. Cases were
more likely to be obese (BMI.30 kg/m
2) and less likely to be
current smokers, although the association with smoking was no
longer present after adjustment for age, sex and study center.
Results from the individual SNP and gene-based minimum p-
value permutation (min-P) tests are shown in Table 1. The
strongest associations with RCC risk were observed for SLC19A1
(Pmin-P=0.03) and MTHFR (Pmin-P=0.13). Two individual SNPs
tagging the SLC19A1 region, rs12483553 and rs17004785, were
significantly associated with RCC after adjustment for multiple
testing (FDR-adjusted Ptrend=0.03 for each). The association for
each SNP was slightly attenuated when both were included
together in the logistic regression model. The haplowalk analysis
also identified SLC19A1 as a region of interest, with an FDR-
adjusted p-value of 0.02 for the most significant 3-SNP window.
Based on the haplowalk analysis and the LD structure among
control subjects, we identified a block of four tag SNPs to examine
in haplotype analysis (rs12483553, rs2838950, rs2838951, and
rs17004785). The A-C-C-C haplotype was associated with a
significant 37% increased RCC risk compared to the most
frequent haplotype, G-C-G-G (Table 3). The two SNPs identified
in the single SNP analysis appear to be driving the haplotype
result, as other haplotypes that did not include the minor allele for
rs12483553 or rs17004785 did not have different RCC risks
relative to the reference haplotype. After stratification, we
observed that both the individual SNPs and the A-C-C-C
haplotype were significantly associated with RCC risk only among
those in the lowest tertile of vegetable intake (Table 4). The overall
distribution of SLC19A1 haplotypes differed significantly (Pglobal
=0.05) between cases and controls within the lowest tertile of
vegetable intake, but not within the middle or highest tertile.
Power was limited, and tests for interaction between individual
Gene Name (alias) Gene Function
Chromosome
Location
Number of
Tag SNPs
Minimum
P-trend
1,2
FDR-
adjusted
P-trend
1,3
Adjusted
Min-P Test
[11] MTRR: 5-Methyltetrahydrofolate-
Homocysteine Methyltransferase
Reductase (MSR, MGC129643)
Involved in the reductive regeneration
of cobalamin cofactor required for the
maintenance of methionine synthase in
a functional state
5p15.3–p15.2 16 0.27 1.00 0.988
[12] GSS: Glutathione Synthetase
(GSHS, MGC 14098)
Catalyzes the second step of
glutathione biosynthesis; glutathione
is important for a variety of biological
functions, including protection of cells
from oxidative damage by free radicals,
detoxification of xenobiotics, and
membrane transport
20q11.2 9 0.47 0.99 0.990
1Adjusted for age, sex and study center.
2Minimum P-value for all tagging SNPs in each gene region using an additive model.
3FDR-adjusted minimum P-value for all tagging SNPs in each gene region using an additive model.
Note: Numbers in brackets [#] correspond to locations on Figure S1.
doi:10.1371/journal.pone.0026165.t001
Table 1. Cont.
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interactions (Table 4). No differences in haplotype distributions or
individual SNP effects were observed in analyses stratified by
alcohol intake for any of the genes examined.
We utilized data from a recent genome-wide association study
(GWAS) of renal cancer [22] with over 3700 Caucasian cases and
8400 controls to look specifically at the association between the
two significant SLC19A1 SNPs identified in our study and RCC
risk in the GWAS population. Both SNPs were associated with
RCC risk (p=0.01 for rs12483553; p=0.04 for rs17004785),
though not at a level sufficient for genome-wide significance in an
agnostic GWAS examination.
A previous analysis by Moore et al. in the CEERCC study
population found a significant association between the known
functional SNP in MTHFR (rs1801133, 677C.T) and RCC risk
[5]. We expanded on the previous result by comprehensively
examining the gene region to evaluate whether additional variants
in the gene were associated with RCC risk, but none were
significant in the single SNP analysis. We identified a region of
interest based on the haplowalk analysis and tested haplotypes to
Table 2. Demographic and lifestyle characteristics of participants in the Central and Eastern European Renal Cell Cancer Study.
All Participants Genotyped Participants
Cases Controls Cases Controls
n % n % P-val
1 n % n % P-val
1
Total 1,097 1,476 777 1,035
Center
Bucharest, Romania 95 8.7 160 10.8 68 8.8 94 9.1
Lodz, Poland 99 9.0 198 13.4 80 8.7 189 18.3
Moscow, Russia 317 28.9 463 31.4 242 31.1 313 30.2
Czech Republic
2 586 53.4 655 44.4 ,0.001 387 49.8 439 42.4 ,0.001
Sex
Male 648 59.1 952 64.5 472 60.8 648 62.6
Female 449 40.9 524 35.5 0.01 305 39.3 387 37.4 0.42
Mean age ± Std Dev (yrs) 59.6610.3 59.3610.3 0.61 59.5610.4 59.0610.2 0.34
Body Mass Index (kg/m2)
,25 327 29.8 532 36.2 222 28.6 375 36.3
25–30 476 43.4 620 42.2 330 42.5 432 41.9
.30 293 26.7 318 21.6 0.001 225 29.0 225 21.8 ,0.001
Smoking Status
Never 510 46.6 599 40.7 359 46.4 420 40.7
Former 251 22.9 353 24.0 174 22.5 246 23.8
Current 333 30.4 521 35.4 0.01 241 31.1 367 35.5 0.04
Hypertension (self-report)
No 600 54.7 906 61.4 434 55.9 638 61.7
Yes 496 45.3 569 38.6 0.001 342 44.1 396 38.3 0.01
Family History of Cancer
3
No 733 66.8 1,074 72.8 512 65.9 745 72.0
Yes 364 33.2 402 27.2 0.001 265 34.1 290 28.0 0.01
Vegetable Intake
4
Low 362 34.0 420 29.3 251 33.2 288 28.6
Medium 426 40.0 542 37.8 311 41.1 391 38.8
High 277 26.0 471 32.9 0.001 194 25.7 329 32.6 0.005
Alcohol intake
5
Non-drinkers 283 25.8 349 23.6 201 25.9 243 23.5
Low 318 29.0 376 25.5 218 28.1 297 28.7
Medium 296 27.0 370 25.1 199 25.6 248 24.0
High 198 18.1 381 25.8 ,0.001 158 20.4 247 23.9 0.25
1Chi-square test for proportions; T-test for means.
2Four centers: Brno, Olomouc, Prague, Ceske-Budejovice.
3Cancer in first-degree relatives.
4Tertiles based on frequency of vegetable intake among controls.
5Tertiles for drinkers, based on weighted average of consumption.
doi:10.1371/journal.pone.0026165.t002
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677C.T SNP (Table 3). Two haplotypes were found to be
significantly associated with RCC risk, but the results are
consistent with variation at 677C.T driving the association.
Stratification by vegetable intake showed that two MTHFR
haplotypes were associated with RCC risk in the low or middle
tertiles (Table 4), while no haplotypes were significant among those
in the highest tertile. However, the effect of vegetable intake on
genotype was relatively weak, as the global p-values for the
haplotypes were not significant in any vegetable tertile and the
tests of interactions had low power but were not significant
(Table 4).
No significant associations were observed for individual SNPs or
the gene-based min-P test for the other one-carbon genes
genotyped in this study (Table 1). Therefore we did not examine
specific haplotypes for these genes. Results for the individual
analyses of all SNPs can be found in Table S1.
Discussion
We conducted an analysis of 163 tag SNPs in 13 genes related
to one-carbon metabolism, folate transport, and glutathione
synthesis in relation to risk of renal cell carcinoma. We identified
one novel gene region that was significantly associated with RCC
risk. Specifically, a region proximal to the coding region of
SLC19A1 was found to contain two SNPs that were associated with
risk of RCC, and a haplotype containing the minor allele for both
these SNPs was associated with a significant 39% increased risk.
The association was particularly evident among participants who
reported low vegetable intake, which may be a proxy for folate
intake/status. Supporting our findings, the two significant
SLC19A1 SNPs in our study were also associated with RCC in a
recent GWAS study of renal cancer [22], though not at a level of
genome-wide significance. Our results are novel and require
replication in other studies that can examine vegetable or folate
intake.
There is a biologic rationale for an involvement of the SLC19A1
gene in cancer risk. SLC19A1 codes for the reduced folate carrier
(RFC), which transports reduced folates and antifolate drugs into
mammalian cells [23]. Humans are unable to synthesize folates,
which are at the foundation of the reactions of one-carbon
metabolism, so adequate folate must be consumed, effectively
absorbed, and transported to cells and tissues. RFC is ubiquitously
expressed, including at high levels in the kidney, and is the major
transport system for folates in most tissues [23]. In addition to
uptake of folate from the blood, RFC is also involved in absorption
of folate in the intestine as well as transport across the basolateral
membrane of the renal tubules [23]. Genetic variations in
SLC19A1 could result in differing RFC activity and therefore
differing folate availability. Folate deficiency has been associated
with a number of cancers, including RCC, through mechanisms
thought to involve its role in the provision of substrates for DNA
synthesis and methylation [2–5].
Existing evidence for an association between SLC19A1 and
cancer risk is sparse. Mouse models suggest that levels of RFC can
dramatically impact the neoplastic processes leading to colorectal
cancer [23]. Variation in SLC19A1 has not been studied in relation
to renal cancer, but epidemiologic studies have examined the
association of this gene with other cancers. Most studies examined
one particular nonsynonymous SNP (rs1051266, 80G.A), which
has been associated with changes in blood concentrations of folate
in some studies [24,25] but not others [26,27]. We did not have
genotype information for this SNP, though it was moderately
correlated with one of our tag SNPs (rs2838951; r
2=0.59). Other
Table 3. Haplotypes in selected one-carbon metabolism genes and risk of renal cell carcinoma.
Haplotypes Cases (%) Controls (%) OR
1 (95% CI) P-value Global P-value
SLC19A1
Region 1
59 - rs12483553, rs2838950, rs2838951, rs17004785 - 39
G-C-G-G 42.5 43.8 1.00 (ref)
A-C-C-C 8.4 6.4 1.37 (1.05–1.78) 0.02
G-C-C-G 20.6 21.0 1.00 (0.83–1.20) 0.99
G-T-C-G 22.8 24.2 0.97 (0.83–1.15) 0.74
Rare 1.20 (0.87–1.64) 0.27
0.13
MTHFR
Region 2
59 - rs12121543, rs1801133, rs17421511, rs11121832, rs9651118 - 39
G-T-C-G-A 33.9 30.2 1.00 (ref)
T-C-T-A-A 18.0 17.6 0.92 (0.75–1.12) 0.40
T-C-C-G-A 10.2 10.1 0.91 (0.72–1.16) 0.44
G-C-C-G-G 23.2 24.4 0.86 (0.72–1.02) 0.09
G-C-C-G-A 5.5 7.0 0.69 (0.51–0.93) 0.01
G-C-C-A-A 7.3 9.4 0.69 (0.53–0.90) 0.01
Rare 1.31 (0.71–2.40) 0.39
0.04
1Adjusted for age, sex, and study center.
doi:10.1371/journal.pone.0026165.t003
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bladder, esophageal, and lung cancers [28–30], but not with colon,
prostate, and breast cancers [31–34]. A recent study examined tag
SNPs of one-carbon genes and found five SNPs in SLC19A1 that
were significantly associated with risk of colorectal adenomas,
including rs1051266 [35]. One of the specific SLC19A1 tag SNPs
found to be associated with RCC risk in our study, rs17004785,
was not associated with risk in the studies of colorectal cancer and
colorectal adenomas [31,35].
Haplotypes in both SLC19A1 and MTHFR were found to be
significantly associated with RCC risk among participants in the
lowest tertile of vegetable intake frequency, but no effect of
genotype was observed among those in the highest tertile.
Vegetables are good sources of folate, particularly in populations
such as Eastern and Central Europe where grain products are not
fortified with folic acid. Thus vegetable intake may be a rough
proxy for folate intake, in which case our results suggest that the
effect of genotype for these folate-associated genes may be
important only when folate intake is low. A number of studies of
MTHFR and cancer risk have demonstrated an increased role of
genetic variation under low-folate conditions [10,36], and
numerous examples support the theory that diet can modify the
impact of genetic variation [37].
To our knowledge, this is the first study to comprehensively
examine variation in one-carbon metabolism and folate transport
genes in relation to renal cancer risk, including examination of
different dietary intakes of folate sources. We used HapMap data
with a tag SNP approach to achieve high (80–90%) genomic
coverage of the genes of interest, and examined regions upstream
and downstream of the coding regions. In addition, the study was
conducted in a population without mandatory fortification of grain
products with folic acid; similar studies in fortified populations
with uniformly high folate intake may not be able to fully examine
the interaction between folate intake and genetic effects related to
folate transport and metabolism. Other strengths of our study were
inclusion of only newly diagnosed and histologically confirmed
renal cancers, a high participation rate, and collection of biological
samples from a high proportion of participants. The multi-stage
analysis and correction for multiple testing reduced the possibility
of Type I error. Population stratification is a possible concern, but
we found no evidence of heterogeneity by country, and bias from
population stratification is unlikely to be substantial in studies of
cancer in non-Hispanic European populations [38]. A limitation of
our study is that the dietary assessment instrument in the CEERC
study was designed specifically to assess intake of the foods most
frequently consumed in the study region, but it did not capture the
quantity of foods consumed. Diet was assessed after case diagnosis,
so recall bias is possible if case status influenced how participants
recalled their dietary habits. Given the limitations in the
assessment of diet and the need for replication, our analyses
should be considered exploratory.
In conclusion, we comprehensively examined genetic variation in
13 genes associated with one-carbon metabolism using a tag SNP
approach and identified a novel association between SLC19A1 and
Table 4. Haplotypes in selected one-carbon metabolism genes and risk of renal cell carcinoma, stratified by frequency of
vegetable intake.
Tertiles of vegetable intake frequency
Low Medium High
Haplotypes OR
1 95% CI OR
1 95% CI OR
1 95% CI P-int
2
SLC19A1
Region 1
59 - rs12483553, rs2838950, rs2838951, rs17004785 - 39
G-C-G-G 1.00 (ref) 1.00 (ref) 1.00 (ref)
A-C-C-C 1.92 (1.17–3.15) 1.05 (0.70–1.58) 1.31 (0.75–2.27) 0.19
G-C-C-G 0.96 (0.69–1.34) 0.95 (0.71–1.28) 0.98 (0.69–1.38) 0.85
G-T-C-G 0.91 (0.67–1.23) 0.91 (0.69–1.18) 1.03 (0.76–1.40) 0.67
P-global 0.05 0.91 0.74
rs12483553
3 1.81 (1.19–2.76) 1.11 (0.77–1.58) 1.32 (0.83–2.11) 0.26
rs17004785
3 2.05 (1.36–3.11) 1.06 (0.76–1.48) 1.30 (0.85–2.01) 0.09
MTHFR
Region 2
59 - rs12121543, rs1801133, rs17421511, rs11121832, rs9651118 - 39
G-T-C-G-A 1.00 (ref) 1.00 (ref) 1.00 (ref)
T-C-T-A-A 0.78 (0.54–1.15) 1.10 (0.80–1.51) 0.89 (0.61–1.29) 0.63
T-C-C-G-A 0.78 (0.49–1.23) 1.10 (0.76–1.59) 0.89 (0.56–1.41) 0.53
G-C-C-G-G 0.73 (0.53–1.01) 0.93 (0.70–1.23) 0.96 (0.68–1.35) 0.21
G-C-C-G-A 0.72 (0.41–1.25) 0.61 (0.38–0.97) 0.87 (0.49–1.55) 0.72
G-C-C-A-A 0.55 (0.33–0.91) 0.73 (0.48–1.12) 0.79 (0.47–1.30) 0.32
P-global 0.34 0.20 0.89
1Adjusted for age, sex, and study center.
2Interactions tested using a likelihood ratio test and adjusting for age, sex, and center.
3Single SNP analysis.
doi:10.1371/journal.pone.0026165.t004
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findings and better understand the impact of folate intake.
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